ATOMIC SARMS
$114
- Extreme Fat Loss
- Metabolic Correction
- Appetite Suppression
Retatrutide is a revolutionary triple-hormone receptor agonist (GLP-1, GIP, and Glucagon). It offers unprecedented weight loss efficacy and profound metabolic correction.
Retatrutide is an investigational synthetic peptide that acts as a triple receptor agonist, simultaneously activating the GLP-1, GIP and glucagon receptors. In clinical trials it has been studied as a once-weekly subcutaneous compound.
Its molecular structure enables potent activation of all three receptors: GLP-1 and GIP signaling is associated with reduced appetite and improved glucose handling, while glucagon activity is associated with increased energy expenditure. In trials this combination produced dose-dependent weight reduction and metabolic improvements.
Retatrutide is an investigational compound that has progressed to Phase 3 clinical trials for indications including obesity, type 2 diabetes, MASLD (fatty liver), obstructive sleep apnea and others. It is not an approved medicine.
Store the lyophilized powder at -20°C, protected from light. Reconstitute with bacteriostatic water added gently down the vial wall, swirl rather than shake, and keep the reconstituted solution refrigerated at 2–8°C.
No. All products are supplied strictly for laboratory and research use only. They are not approved for human or veterinary use, diagnosis, treatment, or consumption.